Loading...
Loading...
India's ketoconazole imports from UNITED STATES total $307.8K across 103 shipments from 15 foreign suppliers. ESPEE BIOPHARMA FINECHEM LLC leads with $123.3K in import value; the top 5 suppliers together control 94.8% of this origin. Leading Indian buyers include TORRENT PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for ketoconazole — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA FINECHEM LLC is the leading Ketoconazole supplier from UNITED STATES to India, with import value of $123.3K across 4 shipments. The top 5 suppliers — ESPEE BIOPHARMA FINECHEM LLC, ESPEE BIOPHARMA & FINECHEM LLC, ZYDUS HEATHCARE USA LLC, NEWLIFE BIOPHARMA LIMITED, PHARMACEUTICAL BUYERS INTERNATIONAL — collectively account for 94.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA FINECHEM LLC | $123.3K | 4 | 40.1% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $113.8K | 7 | 37.0% |
| 3 | ZYDUS HEATHCARE USA LLC | $21.5K | 1 | 7.0% |
| 4 | NEWLIFE BIOPHARMA LIMITED | $18.1K | 1 | 5.9% |
| 5 | PHARMACEUTICAL BUYERS INTERNATIONAL | $15.0K | 4 | 4.9% |
| 6 | AGRACE PHARMA | $3.8K | 6 | 1.2% |
| 7 | RAFF & HALL PHARMACY, | $2.2K | 6 | 0.7% |
| 8 | NOVITIUM PHARMA LLC | $2.1K | 57 | 0.7% |
| 9 | NEWLIFE MEDICALS (USA). INC. | $1.6K | 2 | 0.5% |
| 10 | NEW LIFE MEDICALS (USA),INC. | $1.5K | 3 | 0.5% |
| 11 | AMSTERDAM PHARMA(APTEKA RX INC.) | $1.3K | 1 | 0.4% |
| 12 | AGRACE PHARMA. | $1.2K | 3 | 0.4% |
| 13 | NATIONWIDE MEDICAL SURGICAL | $1.2K | 1 | 0.4% |
| 14 | NEWLIFE MEDICALS USA INC | $776 | 3 | 0.3% |
| 15 | AMSTERDAM PHARMA (APTEKA RX INC.) | $304 | 1 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD | $112.7K | 5 | 36.6% |
| 2 | ENCUBE ETHICALS PRIVATE LIMITED | $91.4K | 10 | 29.7% |
| 3 | TORRENT PHARMACEUTICALS LIMITED | $55.3K | 2 | 18.0% |
| 4 | APDM PHARMACEUTICALS PRIVATE LIMITED | $21.5K | 1 | 7.0% |
| 5 | UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED | $15.0K | 4 | 4.9% |
| 6 | AUROBINDO PHARMA LTD | $3.5K | 7 | 1.1% |
| 7 | ZYDUS LIFESCIENCES LIMITED | $2.2K | 6 | 0.7% |
| 8 | NOVITIUM LABS PRIVATE LIMITED | $2.1K | 57 | 0.7% |
| 9 | ALEMBIC PHARMACEUTICALS LIMITED | $1.5K | 3 | 0.5% |
| 10 | AUROBINDO PHARMA LIMITED | $1.5K | 4 | 0.5% |
| 11 | MACLEODS PHARMACEUTICALS LTD | $1.0K | 3 | 0.3% |
| 12 | DR.REDDY'S LABORATORIES LTD | $5 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ketoconazole suppliers from UNITED STATES to India include ESPEE BIOPHARMA FINECHEM LLC, ESPEE BIOPHARMA & FINECHEM LLC, ZYDUS HEATHCARE USA LLC. The leading supplier is ESPEE BIOPHARMA FINECHEM LLC with import value of $123.3K USD across 4 shipments. India imported Ketoconazole worth $307.8K USD from UNITED STATES in total across 103 shipments.
India imported Ketoconazole worth $307.8K USD from UNITED STATES across 103 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ketoconazole sourced from UNITED STATES include TORRENT PHARMACEUTICALS LTD, ENCUBE ETHICALS PRIVATE LIMITED, TORRENT PHARMACEUTICALS LIMITED. The largest buyer is TORRENT PHARMACEUTICALS LTD with $112.7K in imports across 5 shipments.
The total value of Ketoconazole imports from UNITED STATES to India is $307.8K USD, across 103 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
103 Verified Shipments
15 suppliers, 12 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists